← SynDRA
CHRYSIN
SynDRA canonical compound SYN0000968 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ABCG2 | AKR1B1 | CDK6 | CYP19A1 | CYP1B1 |
|---|
| Mechanism of action | breast cancer resistance protein inhibitor |
|---|
All known targets
- CYP1B1
- AKR1B1
- CDK6
- CYP19A1
- ABCG2
- CYP1A1
- Malaria fabG
Mechanisms of action (all sources)
- CYP1A1 INHIBITOR
- CYP1B1 INHIBITOR
- breast cancer resistance protein inhibitor
- AKR1B1 INHIBITOR
- CYP19A1 INHIBITOR
- Inhibitor
- CDK6 INHIBITOR
Cross-references
Synonyms
- 5,7-Dihydroxyflavone
- Chrysine
- 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one
- Crysin
- 5,7-dihydroxy-2-phenylchromen-4-one
- 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-
- UNII-3CN01F5ZJ5
- NSC 407436
- FLAVONE, 5,7-DIHYDROXY-
- EINECS 207-549-7
- NSC407436
- 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one
- CHEMBL117
- 5,7-Dihydroxy-2-phenyl-chromen-4-one
- BRN 0233276
- 3CN01F5ZJ5
- CHEBI:75095
- RTIXKCRFFJGDFG-UHFFFAOYSA-N
- 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one
- MFCD00006834
- Chrysin, 99+%
- CAS-480-40-0
- DTXCID902396
- 5,7-dihydroxy flavone
- RefChem:5686
- Chrysin 99+%
- Chrysinic acid
- SMR000112318
- SR-01000765660
- Chrysinic acid;
- 3ebo
- 4des
- 5,7-flavonone
- Chrysin (Standard)
- 5,7-diOH-Flavone
- Flavone,7-dihydroxy-
- Chrysin, 97%
Look up CHRYSIN in the interactive SynDRA portal →